All News

Over 65,000 ineligible providers have been culled from the Medicaid program due to a component of the Affordable Care Act (ACA) that requires periodic recertification of eligibility.

The company's study has found a 38% drop in cigarette purchase among shoppers who visit CVS stores.

A recent literature review, examining evidence on lifestyle changes that can reduce the risk of recurrence or death for women diagnosed with breast cancer, found that exercise can reduce the risk of both outcomes.

A popular strategy to help stem the tide of opioid-related deaths has been the implementation of laws that expand access to naloxone, the drug that halts and reverses overdoses. A recent paper has found that these laws did in fact save lives.

The results from the United Kingdom support CMS' decision to add a payment code for collaborative care to this year's Medicare Physician Fee Schedule.

The results follow a separate report that outlined the reasons why low-income workers don't seek preventive care, and what can be done.

Researchers at the American Cancer Society have found that nonelderly cancer survivors enrolled in high-deductible health plans are more likely to seek a change to a lower-cost prescription medication compared with those without a cancer history.

Population-level judgements on the value of therapies to treat multiple sclerosis don’t adequately depict the differences between how providers and payers view value compared with patients and how patients view value different from one another.

Critical access hospitals in rural areas continue to be threatened by unsustainable operating costs, but a recent blog post on Health Affairs proposed an innovative solution to ensure access to care persists in these areas: freestanding emergency centers.

The announcements come as Medicare is set to start reimbursing the Diabetes Prevention Program on January 1, 2018.

Including anti-cholesterol agents during adjuvant endocrine treatment can prevent breast cancer recurrence in hormone receptor—positive early-stage breast cancer.

Here you can access pages highlighted in our Instagram feed.

Two surveys, one each for patients and providers, reveal gaps between patient confidence to manage disease or pain and what they'd like to see from their physicians.

Adverse events from cancer clinical trials are currently reported by trial investigators, but a recent feasibility study found that patients can successfully and accurately report their own symptoms if given the opportunity.

New research indicates that Medicare patients were more likely to continue using opioid painkillers a year after a visit to the emergency department if they had been treated there by a physician that frequently prescribes opioids.

This small study found sustained weight loss of 10% of body weight in patients who were overweight but not obese, along with improvements in glycemic control and quality of life that exceeded patients taking medication only.

The presentation at HIMSS 2017 comes after a record-breaking year in healthcare data breaches.

The trial successfully improved progression-free survival and also tested a BRCA diagnostic test in patients with ovarian cancer.

As CMS moves forward with the Medicare Access and CHIP Reauthorization Act, it is funding organizations to help solo and small practices succeed under the new payment system.

Weill Cornell Medicine and Boehringer Ingelheim have announced a collaboration that will investigate novel approaches to treating chronic respiratory disease.

A study in Diabetes Care examined the effects of high-deductible health plans on healthcare utilization for diabetes patients with varying incomes.

The policy brief outlines House GOP thinking on a universal, refundable, and portable tax credit, state-based high-risk pools, and how to repeal Medicaid expansion. But many specifics, including what it would cost a typical family, are unclear.

A look at Seema Verma’s approach to reforming healthcare policy, and what it could mean for Medicare and Medicaid if she is confirmed as CMS administrator.

An e-mail, from Mark Merritt, president and CEO of the trade group Pharmaceutical Care Management Association, to the organization’s board, lays out a plan to develop an aggressive campaign to convince the new administration that the fault rests with pharmaceutical manufacturers.

This week, the top managed care stories included the end of 2 insurance megamergers, a proposed rule to tighten restrictions for the Affordable Care Act, and new legislation in New Jersey provides the nation's strictest mandates for treating addiction.